MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Parkinsonian disorders may have different pain features.

    SY. Kang, YH. Sung (Hwaseong, Republic of Korea)

    Objective: The aim of this study was whether the pain is a unique feature of Parkinson's disease, which precedes motor symptoms, and its characteristics would…
  • 2022 International Congress

    Outcomes after Deep Brain Stimulation (DBS) surgery in patients with young-onset Parkinson’s disease

    L. Jackson, B. Klassen, K. Lee, K. Miller, A. Hassan, R. Savica (Rochester, USA)

    Objective: To assess outcomes after deep brain stimulation (DBS) in patient with young-onset Parkinson’s disease (PD). Background: DBS is a surgical procedure which effectively treats…
  • 2022 International Congress

    Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

    JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

    Objective: To assess the relationship between volumetric measures of cholinergic basal forebrain (CBF) degeneration and short-latency sensory afferent inhibition (SAI) in Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Botulinum toxin injections are an effective treatment for patients with essential head tremor.

    A. Marques, I. Rieu, B. Pereira, G. Castelnovo, F. Fluchère, C. Laurencin, B. Degos, A. Poujois, A. Kreisler, S. Sangla, M. Tir, I. Benatru, G. Blanchet-Fourcade, D. Guehl, D. Gayraud, L. Tatu, C. Tranchant, D. Amarantini, M. Simonetta, F. Durif (Clermont-Ferrand, France)

    Objective: To assess the safety and efficacy of Botulinum toxin (Btx) injections in essential head tremor (HT) in a multicenter, randomized, double blind, parallel-group, placebo-controlled…
  • 2022 International Congress

    Magnetic Resonance Image-guided high-intensity focused ultrasound (MRIgFUS) subthalamotomy in Spanish Parkinson’s disease (PD) patients.

    M. Campins-Romeu, R. Baviera-Muñoz, C. Morata-Martinez, I. Sastre-Bataller, R. Conde-Sardon, A. Gutierrez-Martin, I. Martinez-Torres (Valencia, Spain)

    Objective: To describe our preliminary results of MRIgFUS subthalamotomy in two PD patients. Background: MRIgFUS thalamotomy has become the preferred surgical approach for refractory essential tremor…
  • 2022 International Congress

    CCL5 promotes Th17 migrating into SNpc by promoting Th17 proportion increase and LFA-1 expression

    XZ. Xue (WuHan, China)

    Objective: To explore the specific pathway by which CCL5 induces Th17 cells migrating into substantia nigra pars compacta (SNpc) to aggravate Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Bilateral Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Medication-Resistant Essential Tremor Treatment.

    O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, N. Mukhamadeeva, G. AKHMADEEVA. (Ufa, Russian Federation)

    Objective: To assess the efficacy and safety of bilateral magnetic resonance imaging-guided focused ultrasound thalamothomy for medication refractory essential tremor in prospective observation of two…
  • 2022 International Congress

    Long non-coding RNAs in Parkinson’s disease: bringing back life to the grey matter?

    S. Acharya, A. Lumley, L. Zhang, V. Stopa, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to discover and delineate the role of novel long non-coding RNAs (lncRNAs) in Parkinson’s disease (PD). Background: LncRNAs have been widely…
  • 2022 International Congress

    Mutant WDR45 leads to altered ferroptosis in β-propeller protein-associated neurodegeneration

    S H. Diaw, C. Ganos, S. Zittel, K. Plötze-Martin, L. Kulikovskaja, A. Westenberger, M. Vos, A. Rakovic, M. Dulovic-Mahlow, K. Lohmann (Lübeck, Germany)

    Objective: To functionally characterize WDR45-mediated BPAN (Beta-propeller protein-associated neurodegeneration). Background: BPAN patients usually present with global developmental delay and autistic features in early childhood and…
  • 2022 International Congress

    A novel platform for home-based, remotely supervised, transcranial direct current stimulation treatment and assessment for Cerebellar ataxia: A randomized, double-blind, sham-controlled, crossover, feasibility study

    N. Inbar, M. Abo-Said, P. Ponger, S. Frenkel-Toledo, M. Brozgol, Z. Hausdorff, Z. Yekutieli, D. Gershman, A. Hilel, A. Ezra, S. Springer, T. Gurevich (Tel Aviv, Israel)

    Objective: To evaluate the feasibility of home-based transcranial direct current stimulation (tDCS) for people with cerebellar ataxia (CA). Background: tDCS induces non-invasive cortical plasticity via…
  • « Previous Page
  • 1
  • …
  • 495
  • 496
  • 497
  • 498
  • 499
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley